BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mcginn CJ, Miller EM, Lindstrom MJ, Kunugi KA, Johnston PG, Kinsella TJ. The role of cell cycle redistribution in radiosensitization: Implications regarding the mechanism of fluorodeoxyuridine radiosensitization. International Journal of Radiation Oncology*Biology*Physics 1994;30:851-9. [DOI: 10.1016/0360-3016(94)90360-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Naida JD, Davis MA, Lawrence TS. The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitization. International Journal of Radiation Oncology*Biology*Physics 1998;41:675-80. [DOI: 10.1016/s0360-3016(98)00134-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Flanagan SA, Krokosky CM, Mannava S, Nikiforov MA, Shewach DS. MLH1 deficiency enhances radiosensitization with 5-fluorodeoxyuridine by increasing DNA mismatches. Mol Pharmacol 2008;74:863-71. [PMID: 18535288 DOI: 10.1124/mol.107.043349] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lawrence TS, Tepper JE, Blackstock AW. Fluoropyrimidine-radiation interactions in cells and tumors. Seminars in Radiation Oncology 1997;7:260-6. [DOI: 10.1016/s1053-4296(97)80024-0] [Cited by in Crossref: 43] [Article Influence: 1.8] [Reference Citation Analysis]
4 Yerly-motta V, Pavy JJ, Nervé P. Screening of five specific cell cycle inhibitors using a T Cell lymphoma cell line synchrony/release assay. Biotechnic & Histochemistry 2009;74:119-28. [DOI: 10.3109/10520299909047963] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
5 Quoix E, Moreau L, Oster J. Radiochimiothérapie optimisée pour le cancer bronchique non à petites cellules localement évolué. Cancer/Radiothérapie 1998;2:590-9. [DOI: 10.1016/s1278-3218(98)80092-9] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 Chufal KS, Rastogi M, Srivastava M, Pant M, Bhatt M. Late chemo-intensification with cisplatin and 5-fluorouracil as an adjunct to radiotherapy: A pragmatic approach for locally advanced head and neck squamous cell carcinoma. Oral Oncology 2006;42:517-25. [DOI: 10.1016/j.oraloncology.2005.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
7 Jamison JM, Gilloteaux J, Nassiri MR, Venugopal M, Neal DR, Summers JL. Cell cycle arrest and autoschizis in a human bladder carcinoma cell line following Vitamin C and Vitamin K3 treatment. Biochem Pharmacol 2004;67:337-51. [PMID: 14698046 DOI: 10.1016/j.bcp.2003.08.040] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
8 Bischof M, Weber K, Blatter J, Wannenmacher M, Latz D. Interaction of pemetrexed disodium (ALIMTA, multitargeted antifolate) and irradiation in vitro. International Journal of Radiation Oncology*Biology*Physics 2002;52:1381-8. [DOI: 10.1016/s0360-3016(01)02794-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
9 Flanagan SA, Cooper KS, Mannava S, Nikiforov MA, Shewach DS. Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization. Int J Radiat Oncol Biol Phys 2012;84:e613-20. [PMID: 22867891 DOI: 10.1016/j.ijrobp.2012.06.050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Gonser S, Crompton NE, Folkers G, Weber E. Increased radiation toxicity by enhanced apoptotic clearance of HL-60 cells in the presence of the pentapeptide thymopentin, which selectively binds to apoptotic cells. Mutat Res 2004;558:19-26. [PMID: 15036115 DOI: 10.1016/j.mrgentox.2003.10.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
11 Ahsan A, Hiniker SM, Davis MA, Lawrence TS, Nyati MK. Role of cell cycle in epidermal growth factor receptor inhibitor-mediated radiosensitization. Cancer Res 2009;69:5108-14. [PMID: 19509222 DOI: 10.1158/0008-5472.CAN-09-0466] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
12 Lee YJ, Lee H, Borrelli MJ. Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity. Cancer Gene Ther. 2002;9:267-274. [PMID: 11896443 DOI: 10.1038/sj.cgt.7700433] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
13 Guo J, Wang Y, Wang J, Zhang J, Fang J. Radiosensitization of oral tongue squamous cell carcinoma by nanosecond pulsed electric fields (nsPEFs). Bioelectrochemistry 2017;113:35-41. [DOI: 10.1016/j.bioelechem.2016.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
14 Hall JA, Rusten M, Abughazaleh RD, Wuertz B, Souksavong V, Escher P, Ondrey F. Effects of PPAR-γ agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies. Head Neck 2020;42:2542-54. [PMID: 32519370 DOI: 10.1002/hed.26286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Belka C, Nieder C, Molls M. Biological Basis of Combined Radio- and Chemotherapy. In: Brown JM, Mehta MP, Nieder C, editors. Multimodal Concepts for Integration of Cytotoxic Drugs. Berlin/Heidelberg: Springer-Verlag; 2006. pp. 3-17. [DOI: 10.1007/3-540-35662-2_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Molls M, Nieder C, Belka C, Norum J. Quantitative Cell Kill of Radio- and Chemotherapy. In: Molls M, Vaupel P, Nieder C, Anscher MS, editors. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies. Berlin: Springer Berlin Heidelberg; 2009. pp. 169-90. [DOI: 10.1007/978-3-540-74386-6_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Shewach DS, Lawrence TS. Nucleoside Radiosensitizers. In: Peters GJ, editor. Deoxynucleoside Analogs In Cancer Therapy. Totowa: Humana Press; 2007. pp. 289-329. [DOI: 10.1007/978-1-59745-148-2_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Lawrence TS. Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression. International Journal of Radiation Biology 2009;70:273-80. [DOI: 10.1080/095530096145003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
19 Berry SE, Kinsella TJ. Targeting DNA mismatch repair for radiosensitization. Seminars in Radiation Oncology 2001;11:300-15. [DOI: 10.1053/s1053-4296(01)80067-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
20 Petereit DG, Kinsella TJ. An approach to radiosensitizing cervical cancer by use of chemical modulators of nucleoside metabolism. Seminars in Radiation Oncology 1997;7:324-34. [DOI: 10.1016/s1053-4296(97)80032-x] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
21 Lawrence TS, Chang EY, Hahn TM, Hertel LW, Shewach DS. Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine. Int J Radiat Oncol Biol Phys. 1996;34:867-872. [PMID: 8598364 DOI: 10.1016/0360-3016(95)02134-5] [Cited by in Crossref: 228] [Cited by in F6Publishing: 199] [Article Influence: 9.1] [Reference Citation Analysis]
22 Formenti SC, Dunnington G, Uzieli B, Lenz H, Keren-rosenberg S, Silberman H, Spicer D, Denk M, Leichman G, Groshen S, Watkins K, Muggia F, Florentine B, Press M, Danenberg K, Danenberg P. Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-Fluorouracil and radiation therapy. International Journal of Radiation Oncology*Biology*Physics 1997;39:1059-68. [DOI: 10.1016/s0360-3016(97)00506-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]